Approval · Notice of Compliance 15430 · 2014
PIMOZIDE: Notice of Compliance 15430
Issued March 19, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15430
- Date
- March 19, 2014
- Company
- AA Pharma Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification numbers
- Therapeutic class
- Antipsychotic
- Canadian reference product
- ORAP (Janssen-Ortho Inc.)